The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Candel Therapeutics Inc (NASDAQ: CADL) was $6.4 for the day, up 0.79% from the previous closing price of $6.35. In other words, the price has increased by $0.79 from its previous closing price. On the day, 0.86 million shares were traded. CADL stock price reached its highest trading level at $6.48 during the session, while it also had its lowest trading level at $6.11.
Ratios:
Our analysis of CADL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 4.64. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.02.
On February 20, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $25.
On February 19, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.Canaccord Genuity initiated its Buy rating on February 19, 2025, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 28 ’25 when Nichols William Garrett sold 937 shares for $6.98 per share. The transaction valued at 6,540 led to the insider holds 52,493 shares of the business.
Nichols William Garrett sold 781 shares of CADL for $3,936 on Jun 30 ’25. The Chief Medical Officer now owns 52,493 shares after completing the transaction at $5.04 per share. On Jun 30 ’25, another insider, WILLIAM GARRETT NICHOLS, who serves as the Officer of the company, bought 3,593 shares for $4.90 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 320657280 and an Enterprise Value of 236900016.
Stock Price History:
The Beta on a monthly basis for CADL is -0.89, which has changed by 0.18959105 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $3.79. The 50-Day Moving Average of the stock is 9.46%, while the 200-Day Moving Average is calculated to be 0.39%.
Shares Statistics:
CADL traded an average of 933.10K shares per day over the past three months and 567370 shares per day over the past ten days. A total of 49.25M shares are outstanding, with a floating share count of 36.70M. Insiders hold about 31.18% of the company’s shares, while institutions hold 37.81% stake in the company. Shares short for CADL as of 1753920000 were 6464874 with a Short Ratio of 6.93, compared to 1751241600 on 6580198. Therefore, it implies a Short% of Shares Outstanding of 6464874 and a Short% of Float of 16.72.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
